Hemostatic Embolization
Emergency procedure to occlude the artery responsible for active bleeding via endovascular approach, regardless of the organ involved.
Hemostatic Embolization
Synonyms : embolization for active hemorrhage, emergency bleeding embolization, hemostatic embolization
Background and indications
Hemostatic embolization is an emergency endovascular intervention to occlude an artery responsible for active bleeding. It is a vital minimally invasive treatment for life-threatening hemorrhages, as an alternative or complement to surgical hemostasis. Main indications include:
- Post-traumatic hemorrhage (spleen, liver, kidney, pelvis — trauma management)
- Gastrointestinal hemorrhage (ulcers, diverticula, angiodysplasia, post-surgical)
- Post-operative hemorrhage (after pancreatectomy, hepatectomy, pelvic surgery)
- Hemoptysis (bronchial arteries — tuberculosis, aspergilloma, cancer)
- Severe epistaxis refractory to packing
- Obstetric hemorrhage (post-partum — see dedicated page)
Pre-procedure assessment
In emergency, contrast-enhanced CT (arterial and portal phase) is the key examination: it localizes active bleeding (contrast extravasation) and guides catheterization. Blood panel (CBC, coagulation, blood type/crossmatch) and hemodynamic resuscitation (fluid, transfusion) proceed in parallel.
Procedure
Under local anesthesia (± sedation or general anesthesia if patient unstable), a catheter is introduced through the femoral artery. Under fluoroscopic guidance, arteriography identifies the bleeding site. The responsible artery is super-selectively catheterized and embolization performed with microparticles (PVA, gelatin), microcoils, or acrylic glue depending on context. Embolization must be as selective as possible to minimize organ ischemia. The procedure takes 1 to 3 hours.
Results and scientific evidence
Technical success rate (bleeding cessation) is 85-95%. For gastrointestinal hemorrhage, recurrence rate is 10-20% (retreatable by embolization or surgery). For splenic and hepatic trauma, embolization revolutionized management by enabling non-operative treatment in 80-90% of cases. For hemoptysis, bronchial artery embolization offers immediate control in 90-95% of cases.
Risks and complications
Organ ischemia (5-10%, usually partial and reversible), non-target embolization (2-5%), post-embolization syndrome (pain, fever: 20-30%), hemorrhagic recurrence (10-20%). Mortality relates to initial hemorrhage severity and comorbidities, not the procedure itself.
Recovery
ICU or continuous monitoring hospitalization depending on severity. Control CT at 24-48h. Recovery depends on clinical context.
Practical information
The procedure is performed as an emergency inpatient procedure. It is performed by an interventional radiologist, in coordination with the intensivist, surgeon, and on-call teams.
Français
English